Resistance to nonnucleoside reverse-transcriptase inhibitors and prevalence of HIV type 1 non-B subtypes are increasing among persons with recent infection in Spain

Carmen De Mendoza; Carmen Rodriguez; Javier Colomina; Concepción Tuset; Federico Garcia; Jose M. Eiros; Angelica Corral; Pilar Leiva; Jesús Aguero; Julián Torre-Cisneros; José Pedreira; Isabel Viciana; Jorge Del Homero; Ana Saez; Raúl Ortiz De Lejarazu; Vincent Soriano

Journal ArticleOPEN ACCESS

Resistance to nonnucleoside reverse-transcriptase inhibitors and prevalence of HIV type 1 non-B subtypes are increasing among persons with recent infection in Spain

Clinical Infectious Diseases (2005) 41(9) 1350-1354

DOI: 10.1086/496982

54Citations

20Readers

Abstract

The prevalence of drug resistance mutations was 12.1% among 198 persons who experienced human immunodeficiency virus (HIV) seroconversion identified in Spain during 1997-2004. There was a significant increase of K103N and of non-B subtypes over time. Transmission of HIV infection around the time of seroconversion was shown in 8 couples and in 2 clusters of 3 individuals. © 2005 by the Infectious Diseases Society of America. All rights reserved.

Cite

CITATION STYLE

APA

De Mendoza, C., Rodriguez, C., Colomina, J., Tuset, C., Garcia, F., Eiros, J. M., … Soriano, V. (2005). Resistance to nonnucleoside reverse-transcriptase inhibitors and prevalence of HIV type 1 non-B subtypes are increasing among persons with recent infection in Spain. Clinical Infectious Diseases, 41(9), 1350–1354. https://doi.org/10.1086/496982

Resistance to nonnucleoside reverse-transcriptase inhibitors and prevalence of HIV type 1 non-B subtypes are increasing among persons with recent infection in Spain

Abstract

Cite

Register to see more suggestions